Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ribosomal protein S6 pseudogene (ENSG00000214908) is a genomic sequence similar to the functional ribosomal protein S6 (RPS6) gene, but it is categorized as a pseudogene due to disruptions or lack of regulatory elements that prevent it from producing a functional protein[4][7]. While the parental RPS6 is part of the small (40S) subunit of the ribosome with critical roles in protein synthesis, cell growth, and proliferation[3][5], its pseudogenes are typically non-functional remnants within the genome, often arising from genomic duplication or retrotransposition events[1][7]. Most pseudogenes, including ribosomal protein S6 pseudogenes, have no established biological or disease roles, though in rare cases, some may act through RNA-mediated regulatory mechanisms with their parental gene[4][7]. Use of pseudogene entries as drug targets is not appropriate unless there is experimental evidence for a regulatory or functional role[4]. Ribosomal protein S6 pseudogenes are nonfunctional gene copies related to the ribosomal protein S6, which itself has well-defined cellular functions[3]. Pseudogenes are generally not therapeutic targets and should be considered incorrect/invalid as molecular drug targets unless compelling new data demonstrate a regulatory or functional role[4][7]. The most accurate naming for such targets is "Ribosomal protein S6 pseudogene" without a canonical abbreviation or active target role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S6 pseudogene.